Trupanion (NASDAQ:TRUP – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect Trupanion to post earnings of ($0.18) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its earnings results on Thursday, February 15th. The financial services provider reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.13. The business had revenue of $295.50 million during the quarter, compared to analyst estimates of $289.84 million. Trupanion had a negative net margin of 4.03% and a negative return on equity of 15.19%. The company’s revenue for the quarter was up 20.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.23) earnings per share. On average, analysts expect Trupanion to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Trupanion Stock Performance
Shares of Trupanion stock traded down $0.13 on Tuesday, hitting $23.87. 8,136 shares of the company were exchanged, compared to its average volume of 654,455. Trupanion has a 1-year low of $18.45 and a 1-year high of $37.71. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The company has a 50-day moving average price of $25.72 and a 200 day moving average price of $26.83.
Analyst Ratings Changes
Read Our Latest Report on Trupanion
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- How to Use the MarketBeat Stock Screener
- McDonald’s Trend Following Signal is an Opportunity Today
- How to Most Effectively Use the MarketBeat Earnings Screener
- CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Did the Rally in Coca-Cola Company Stock Just Fizzle Out?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.